Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$96.12 USD

96.12
370,120

+0.08 (0.08%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $96.15 +0.03 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Omnicell Continues to Pursue Buyouts, Costs on the Rise

Omnicell (OMCL) progresses well with its strategy to grow inorganically. Rising operating expenses a concern.

    Cardiovascular Systems Portfolio Strong, Competition Rife

    Cardiovascular Systems (CSII) suffers a long history of net loss since its launch in 1989 with no immediate solution in sight.

      Here's Why You Should Invest in Penumbra (PEN) Stock Now

      The market is quite upbeat about Penumbra's (PEN) recently-closed buyout of a controlling stake in MVI Health, aimed at capturing the great potential of virtual reality application.

        Here's Why You Should Retain IDEXX (IDXX) in Your Portfolio

        IDEXX (IDXX) continues to see strong organic growth. Adverse currency movement is a concern.

          Here's Why You Should Retain QIAGEN (QGEN) in Your Portfolio

          A tough competitive landscape and strong reliance on relationships with collaborative partners is a major deterrent to QIAGEN (QGEN). The company's increased focus on the NGS portfolio is a positive.

            Genomic Health (GHDX) Hits a 52-Week High: What's Driving It?

            Genomic Health (GHDX) sees increasing private coverage for the Oncotype DX GPS test within the prostate cancer space.

              Sapna Bagaria headshot

              4 Stocks to Bet on the Burgeoning Home Healthcare Industry

              Growing senior population, increasing chronic illness, high cost of treatment at inpatient settings and preference by patients drives demand for home health care.

                Amedisys Ties Up With Medalogix to Boost Home Health Unit

                Amedisys (AMED) pursues deals to boost Home Health business.

                  Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

                  Style Box ETF report for FYC

                    Why Is Amedisys (AMED) Up 18.5% Since Last Earnings Report?

                    Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                      Awantika Poddar headshot

                      6 Top Stock Options for Millennials Right Now

                      Millennials is the term generally applicable to individuals whose birth years ranges between 1981 and 1996

                        Zacks.com featured highlights include: Vitamin Shoppe, North American Construction, Verso, Amedisys and Heidrick & Struggles

                        Zacks.com featured highlights include: Vitamin Shoppe, North American Construction, Verso, Amedisys and Heidrick & Struggles

                          Sweta Killa headshot

                          S&P 500 Tops 2,900: Best ETFs & Stocks of Best Sectors

                          While nine of the S&P 500 sectors are performing well, information technology is leading the rally followed by consumer discretionary and healthcare.

                            Nilanjan Choudhury headshot

                            5 Stocks With Relative Price Strength to Boost Your Returns

                            Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

                              Awantika Poddar headshot

                              5 Mid-Cap Stocks For Growth Investors to Buy Right Now

                              Investing in mid-cap companies is a safe bet, especially during economic downturns and stringent credit conditions.

                                Sweta Killa headshot

                                5 Growth Stocks at New Highs with Room for More Upside

                                We have highlighted five growth stocks that hit all-time highs in the current market rally and will likely to continue to move higher given their superior fundamentals.

                                  Here's Why You Should Add Amedisys (AMED) to Your Portfolio

                                  Amedisys (AMED) witnesses solid Medicare and non-Medicare revenues at Home Health and Hospice divisions. A favorable demographic trend bodes well.

                                    Will Strong RTG Arm Shape Medtronic's (MDT) Q1 Earnings?

                                    Medtronic (MDT) poised to gain on continued growth in RTG business in Q1.

                                      Will Solid Diabetes Arm Drive Medtronic's (MDT) Q1 Earnings?

                                      Medtronic (MDT) poised to gain on strength in Diabetes business in Q1 on continued uptake of MiniMed 670G system in the United States along with enhanced sensor supply capacity.

                                        Haemonetics Strong on Plasma Unit Amid Blood Center Weakness

                                        Haemonetics (HAE) witnesses strong growth in Plasma franchise. Dullness in Blood Center business prevails.

                                          Hologic Launches Fluent Fluid Management System, Widens Suite

                                          Hologic (HOLX) adopts initiatives to boost the GYN Surgical segment.

                                            Amedisys (AMED) Shares March Higher, Can It Continue?

                                            As of late, it has definitely been a great time to be an investor in Amedisys, Inc. (AMED).

                                              Amedisys (AMED) Grows on Robust Home Health, Personal Care

                                              Amedisys' (AMED) solid performance in Personal Care division is impressive. Plus, a favorable demographic trend and calculating buyouts bode well for the company.

                                                Here's Why You Should Invest in Align Technology (ALGN) Now

                                                We are upbeat about Align Technology's (ALGN) solid Invisalign Technology prospects and growth in North America and internationally.

                                                  Medtronic Launches IN.PACT Admiral in Japan, Boosts APV Arm

                                                  Medtronic's (MDT) recent launch of IN.PACT Admiral DCB in Japan is expected to boost the top line.